Medtronic (MDT) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Medtronic (MDT) has outperformed TransMedics Group (TMDX) over the past year, losing 13.0% versus a loss of 29.6%. Over five years, TMDX leads with a +205.3% price change compared with -33.1% for MDT. Medtronic is the larger company by market cap ($112.24 billion vs $2.74 billion), about 41.0 times the size, while TransMedics Group is growing revenue faster (+37.1% vs +8.4%).
On valuation, Medtronic trades at a lower forward P/E (13.7x vs 35.0x for TransMedics Group). Medtronic pays a dividend yielding 3.25%, while TransMedics Group does not currently pay one. TransMedics Group converts more of its revenue into profit, with a net margin of 31.4% versus 13.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDT | TMDX |
|---|---|---|
| Share price | $87.75 | $79.00 |
| Market cap | $112.24B | $2.74B |
| 1-day change | +2.62% | -2.55% |
| YTD return | -10.98% | -33.36% |
| 1-year return | -13.04% | -29.61% |
| 5-year return | -33.06% | +205.35% |
| P/E ratio (TTM) | 21.56 | 20.47 |
| Forward P/E | 13.68 | 35.05 |
| EPS (TTM) | $4.07 | $3.86 |
| Dividend yield | 3.25% | 0.00% |
| Annual dividend | $2.85 | $0.00 |
| Revenue (latest FY) | $36.36B | $605.49M |
| Revenue growth (YoY) | +8.43% | +37.13% |
| Net income (latest FY) | $4.80B | $190.29M |
| Gross margin | 65.02% | 59.92% |
| Operating margin | 17.78% | 17.93% |
| Net margin | 13.20% | 31.43% |
| 52-week high | $106.33 | $156.00 |
| 52-week low | $73.31 | $60.11 |
| Distance from 52-week high | -17.47% | -49.36% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +19.02% | +26.35% |
| Average volume | 11.49M | 815.54K |
| Shares outstanding | 1.28B | 34.68M |
| Employees | 95,000 | 898 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medtronic is about 41.0 times larger than TransMedics Group by market value ($112.24B vs $2.74B).
- MDT has outperformed TMDX by 16.6 percentage points over the past year.
- Medtronic offers a meaningfully higher dividend yield (3.25% vs 0.00%).
- TransMedics Group is more profitable, keeping 31.4 cents of every revenue dollar as net income versus 13.2 cents for Medtronic.
- TransMedics Group grew revenue faster in its latest fiscal year (+37.13% vs +8.43%).
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 898 employees
MDT vs TMDX FAQ
Which is bigger, Medtronic or TransMedics Group?
Medtronic (MDT) is larger, with a market capitalization of $112.24B compared with $2.74B for TransMedics Group (TMDX).
Which stock has performed better over the past year, MDT or TMDX?
MDT returned -13.04% over the past 12 months, compared with -29.61% for TMDX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MDT or TMDX?
TMDX has the lower trailing P/E at 20.5, versus 21.6 for MDT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Medtronic or TransMedics Group?
Medtronic pays a dividend yielding 3.25%, while TransMedics Group does not currently pay a regular dividend.
Are Medtronic and TransMedics Group in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.